Autosomal Dominant Epidermolytic Ichthyosis: A Patient Guide

Autosomal dominant epidermolytic ichthyosis (EI) is a rare genetic disorder that fundamentally alters the structure and resilience of the skin. At its core, EI is a condition of skin fragility caused by mutations in the KRT1 or KRT10 genes, which are responsible for producing the essential “scaffolding” proteins that hold skin cells together ^[1]. When these proteins are faulty, the top layer of skin loses its internal support, making it prone to blistering and the development of thick, protective scales ^[2].

Importantly, EI is not contagious, and it is not caused by anything a parent did during pregnancy. It is a lifelong, highly variable condition.

The journey of living with EI typically follows a common “two-phase” pattern that begins at birth, though individual experiences vary widely. Newborns often experience intense skin redness and widespread, superficial blistering because their skin is exceptionally delicate ^[3]. As many individuals grow older, the frequency of blistering often decreases (though it can persist), and the skin begins to overcompensate for its fragility by producing an excess of skin cells. This leads to the second phase, characterized by hyperkeratosis, or the buildup of thick, verrucous (very thickened) scales that are most prominent in the creases of the body and around the joints ^[4].

Managing EI requires a lifelong, daily commitment to intensive skin care. The cornerstone of therapy is a customized routine of therapeutic bathing and the liberal application of emollients (moisturizers) to soften the scales, maintain skin flexibility, and prevent painful cracking ^[5]. Because the skin barrier is permanently disrupted, individuals must also remain vigilant against infections and manage chronic symptoms like persistent itching and pain, which can significantly impact daily activities and emotional well-being ^[6].

While EI presents unique challenges at every stage of life, understanding the underlying biology and the typical shifts in symptoms allows for a more proactive approach to care. By working with a specialized medical team, patients and families can tailor their routines to protect the skin’s fragile barrier while minimizing the burden of the disease. With consistent management and supportive care, it is possible to reduce complications and focus on maintaining a high quality of life ^[7].